KalVista Pharmaceuticals, Inc.: KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results
Sebetralstat Phase 3 KONFIDENT and KVD824 Phase 2 KOMPLETE Clinical Trial Enrollment on Track - Formal Notification Received of Sebetralstat EU Orphan Drug Status - KalVista Pharmaceuticals, Inc.